how long have glp-1 been on the market GLP-1R Agonists for Weight Loss The Multi-Sector Impacts of GLP-1RA

Sunny reportedly used Mounjaro.

Uninsured patients represent one of the fastest-growing populations seeking weight loss medication, driven by rising obesity rates and limited employer-sponsored coverage options

To date, only one clinical trial has investigated the effects of a GLP-1 agonist, exenatide, on individuals seeking treatment for AUD 11

C.YamadaA.KimuraS.et al

A., and Kalinsky K., Genomic Alterations (GA) in ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2() Patients (Pts) With Metastatic Breast Cancer (MBC): CoOccurrence and Prevalence Along Treatment Course, Journal of Clinical Oncology 42 (2024): 1060

These data suggest that GLP-1R agonism attenuates atherosclerosis formation and vascular immune cell activation most likely by reducing systemic inflammation independently of changes in lipid and glucose metabolism